Bio-Rad's $24M DNA Patent Win Backed By Evidence: Judge

Law360 (July 9, 2019, 11:45 PM EDT) -- A Delaware federal judge on Tuesday upheld a $24 million jury verdict for Bio-Rad in a patent suit over a droplet-based method of manipulating DNA, ruling the jury’s decision finding 10X Genomics Inc. had infringed three patents was “supported by substantial evidence.” 

U.S. District Judge Richard G. Andrews on Tuesday shot down 10X's December motion requesting a new trial or judgment as a matter of law that its droplet technology products don’t infringe the patents belonging to Bio-Rad Laboratories Inc. and the University of Chicago, that infringement wasn’t willful, and that the plaintiffs’ claims weren’t valid.

Among other qualms with the verdict, 10X...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS